ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,862.82
0.82%
US Tech 100
19,902.00
0.85%
Dow Jones
43,080.74
0.51%
Brent Oil
77.35
-0.15%
Bitcoin
65,827.07
4.74%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Genfit (GNFT) Quote

Genfit

Genfit (GNFT)

Genfit SA
5.48
0.08
(1.48%)
Closed October 14 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
5.48
Bid
5.40
Ask
5.49
Volume
467,976
5.19 Day's Range 5.50
2.84 52 Week Range 5.79
Market Cap
273.096M
Previous Close
5.40
Open
5.47
Last Trade
144
@
5.48
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
229,784
Shares Outstanding
49,834,983
Dividend Yield
-
PE Ratio
-9.45
Earnings Per Share (EPS)
-0.58
Revenue
38.68M
Net Profit
-28.89M

About Genfit

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.genfit.com
Headquarters
Loos, Nord, Fra
Founded
-
Genfit is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNFT. The last closing price for Genfit was 5.40 €. Over the last year, Genfit shares have traded in a share price range of 2.84 € to 5.79 €.

Genfit currently has 49,834,983 shares outstanding. The market capitalization of Genfit is 269.11 € million. Genfit has a price to earnings ratio (PE ratio) of -9.45.

Ask ADVFN Intelligence (AI)

GNFT Latest News

More News

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval Lille (France), Cambridge...

September 23 2024
UK Regulatory

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA américaine

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA...

September 23 2024
UK Regulatory

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 23, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to...

September 23 2024
GlobeNewswire Inc.

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société Trésorerie et équivalents de trésorerie s’élevant à 61,6 millions d’euros au 30 juin 2024 n’incluant...

September 19 2024
UK Regulatory

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone...

September 19 2024
UK Regulatory

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update

Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June 2024 (received in August 2024) upon first sale of Ipsen’s Iqirvo®...

September 19 2024
GlobeNewswire Inc.

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July...

July 26 2024
UK Regulatory

GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive

GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive Lille (France), Cambridge (Massachusetts...

July 26 2024
UK Regulatory

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 26, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving...

July 26 2024
GlobeNewswire Inc.

GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial

GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 9 juillet 2024 –...

July 09 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.6413.22314049594.845.54.793274305.1778057DE
41.65543.26797385623.8255.593.7854397734.83284094DE
121.4736.65835411474.015.593.522297844.49765174DE
262.15564.81203007523.3255.793.132874174.40808339DE
522.44580.56013179573.0355.792.842487323.9777999DE
1562.2167.58409785933.275.792.7462056173.85778083DE
260-7.6-58.103975535213.0820.962.7463058115.74775466DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALGAUGaussin
0.1202 €
(189.64%)
1.88M
ALACTActicor Biotech
0.86 €
(64.75%)
616.06k
ALAGOEPango SA
0.1092 €
(62.99%)
10.5M
IVAInventiva
2.53 €
(54.27%)
1.03M
ALLAMLlama Group SA
1.24 €
(25.63%)
373.45k
INAInapa Inv Part Gestao
0.005 €
(-50.00%)
15.05M
ALNEVNeovacs
0.0003 €
(-25.00%)
100.08M
MLFXOFinaxo
0.69 €
(-24.18%)
22
CBRRobertet CDV
95.00 €
(-20.17%)
12
ALDOLDolfines
0.0005 €
(-16.67%)
31.59M
ALNEVNeovacs
0.0003 €
(-25.00%)
100.08M
BCPBanco Comercial Portugues SA
0.4317 €
(-0.37%)
70.06M
ALDOLDolfines
0.0005 €
(-16.67%)
31.59M
ALNRGEnergisme SA
0.0065 €
(6.56%)
29.77M
ALRPDRapid Nutrition
0.068 €
(-8.85%)
17.69M

Discussion

View Full Feed
ksquared ksquared 3 minutes ago
We shall see. That ought to be a hoot!
PRmaniac PRmaniac 3 minutes ago
Over 2.5 BILLION SHARES DILUTED SINCE 2023
dilution has been rampant, and they were forced to raise the share authorization once again.
They will likely need to do this again this fall, since they don't have enough shares to issue in their toxic deathspiral.
Outstanding Shares
AAPJ
jc96 jc96 3 minutes ago
This was the company that built Trumps websites in 16. Skyrocketed, then crashed. There were some posts on other boards saying this co may be working on a crypto project with Trump. Just being on good terms with Trump is enough for people to speculate that this will skyrocket again, like Trumps m
PHUN
MiamiGent MiamiGent 3 minutes ago
Yup, TRUMP, JD VANCE, ROBERT F. KENNEDY Jr., TULSI GABBARD Board's onsite reporter! :)
rikkie rikkie 3 minutes ago
WHY are you here then?
LWLG
pepeoil pepeoil 3 minutes ago
No kidding, these boiler room coke heads believe their own chit. Why did cohen have a merchant account loan that he didn’t pay if he was so rich? Lol. His deposition is coming up. He is getting sued. That is fact
GPLS
GoonOfWallSt GoonOfWallSt 4 minutes ago
Still ol’ scam and same pumpsh!t squad… nothing changes except for jmoney360 and Lolo12 disappearance… rumor is they got married and are living happily in Scamus’s basement… and punkin farmah brings them fresh pumpkins daily… lmfao whoooooo……
RNVA
ksquared ksquared 4 minutes ago
Kamala already has the woke zombies. This will help expose her to the independents. And she can reach a swath of independent voters, more of whom watch Fox News than CNN or MSNBC, according to research by Nielsen. I'm torn about watching. I can't stand looking at or listening to her. Stupidi
IHuser IHuser 4 minutes ago
imo.. attention citizens of earth... Ms. WOLF... is plainly claiming that a subversive war of clandestine biological aggression is being wrought on the general unsuspecting populations of "nation states" by controllers and sponsors of this ticker...

Let that sink in~ what are y
PFE
cashclan cashclan 4 minutes ago
Bigger question


Who keeps pissing on the telephone booths

It about time for some connectivity...
PTEL
jsc52033 jsc52033 4 minutes ago
yep something is wrong with tthe audit it dosen't show the numbers Nils wnats so he is looking for a new auitor
excuse is this one go sick aand can't finish it news coming
BMXI
Zorax Zorax 4 minutes ago
Breaking: Steve jaba da cheung may be out of a job soon. Seems like a shake up in mussolini camp. Allegedly two top campaign spokestupids are being pushed aside. Butthead and beaner shuttled maybe. cheeto mussolini isn't going to reveal trouble if he can help it this close to the finish line.
oystersnbeer oystersnbeer 4 minutes ago
Donald Trump's mind is slipping~

https://x.com/votevets/status/1845885970949750922
crazy horse 0 crazy horse 0 4 minutes ago
Israel's War on Journalism

https://t.me/Middle_East_Spectator/11042
Over four days last week, the Israeli military killed two journalists and severely injured at least three others.

On Wednesday, October 9, as attacks intensified in northern Gaza, the military ta
delerious1 delerious1 4 minutes ago
2038 HorsePower........Hyperion.....Hydrogen powered

https://cdn.prod.website-files.com/5d6969dafaa2a0ecb5410d23/6351e1996fee75a9f9542e15_xp1-track-salt_flats_v2.webp
RONN
boston127 boston127 5 minutes ago
5s are up. This could be the beginning

of a turnaround.
IGPK
RickNagra RickNagra 5 minutes ago
Oh wow $1.51 closing price.
FNMA
MiamiGent MiamiGent 5 minutes ago
The big thing now is keeping Trump alive.
luckydude777 luckydude777 5 minutes ago
Had I bought DJT at $11.00 it would have dropped to $5.00 by now. Just sayin ...
DJT
DanM51 DanM51 6 minutes ago
Maybe I can buy that used starship. What's a used one go for? Always wanted one....Have a feeling the guy that bought the Spanish villa by selling lwlg near its highs never stops smiling and laughing. Hope he/she knows how lucky they were......
LWLG
pepeoil pepeoil 6 minutes ago
I love it she the ir guy gets on here and shows the true colors. Stinky pinky trash
GPLS
Zadie420 Zadie420 6 minutes ago
Yep. Me 2. But damn CS I have to wait till next Monday. I don’t wanna Xfer my acct to Fidelity since we are so close to approval.
NWBO
Ragnar Ragnar 6 minutes ago
No chance this goes to $1 this week. 99.998% chance this is back in trips.
RDAR
iamthe walrus iamthe walrus 6 minutes ago
Zygle Co Ltd and their largest shareholder Jin Hee Lee ( 60 plus % in Zygle ) according to the Korean stock market disclosures . Jin Hee Lee is also on ZaiCell Incs board here in the USA . He made a big investment into building a Korean FLP battery / USA joint venture Battery GIGA plant in the USA
CRTG GIGA

Your Recent History

EU
GNFT
Genfit
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved